Cargando…
The role of fenofibrate in the treatment of COVID-19
In December 2019, a severe pneumonia-like illness emerged in the city of Wuhan, China which inevitably led to the Coronavirus disease-19 (COVID-19) pandemic caused by the SARS-CoV-2 virus. Due to the increase in infectivity and mortality caused by the virus, multiple therapeutic regimens are being s...
Autores principales: | Yasmin, Farah, Zeeshan, Muhammad Hamayl, Ullah, Irfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563083/ https://www.ncbi.nlm.nih.gov/pubmed/34745595 http://dx.doi.org/10.1016/j.amsu.2021.102974 |
Ejemplares similares
-
The revival of telemedicine in the age of COVID-19: Benefits and impediments for Pakistan
por: Farooqi, Maheera, et al.
Publicado: (2021) -
Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country
por: Asghar, Muhammad Sohaib, et al.
Publicado: (2022) -
Dengue outbreak in the times of COVID-19 pandemic: Common myths associated with the dengue
por: Zaheer, Saba, et al.
Publicado: (2022) -
Development and Validation of RP-HPLC Method for Simultaneous Estimation of Atorvastatin Calcium and Fenofibrate in Tablet Dosage Forms
por: Jain, N., et al.
Publicado: (2008) -
A Significant Increase of Estimated Glomerular Filtration Rate After Switching From Fenofibrate to Pemafibrate in Type 2 Diabetic Patients
por: Yanai, Hidekatsu, et al.
Publicado: (2021)